The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s aspirin market report forecasts the aspirin market size to grow to $2.92 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Aspirin Market Report 2023 – https://www.thebusinessresearchcompany.com/report/aspirin-global-market-report

Aspirin Market Size Forecast
The global aspirin market is expected to grow from $2.36 billion in 2022 to $2.45 billion in 2023 at a compound annual growth rate (CAGR) of 4.14%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global aspirin market size is expected to grow to $2.92 billion in 2027 at a CAGR of 4.41%.

Asia-Pacific held the largest aspirin market share.

Key Aspirin Market Driver ­– Increase In The Prevalence Of Arthritis
According to a research released by the Centres for Disease Control and Prevention, a US-based national public health body, one in every four adults in the US has doctor-diagnosed arthritis, amounting to over 58.5 million people. By 2040, the figure is predicted to rise to 78.4 million. As a result, the rising prevalence of arthritis is propelling the aspirin industry forward.

Request for A Sample Of The Global Aspirin Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9154&type=smp

Key Aspirin Market Trend – Product Innovation
To maintain their market position, major aspirin firms are producing novel products such as VAZALORETM liquid-filled aspirin capsules. For example, PLx Pharma, a specialised pharmaceutical firm based in the United States, will launch VAZALORETM 325 mg and VAZALORETM 81 mg liquid-filled aspirin capsules in August 2021. The new medication is the first US FDA-approved liquid-filled aspirin capsule and is superior to immediate-release aspirin in preventing stomach erosions and ulcers. VAZALORE is a revolutionary aspirin with a unique administration system designed to protect the stomach, even if cardiologists continue to recommend aspirin for their cardiovascular disease patients. VAZALORE distributes aspirin differently from enteric-coated and plain aspirin formulations. Aspirin is released selectively from the capsule’s unique structure, avoiding stomach contact. VAZALORE combines the potentially life-saving qualities of aspirin with fast, consistent pain relief absorption.

Aspirin Market Segment
1) By Product: Prescription, OTC
2) By Route Of Administration: Oral, Rectal, Parenteral
3) By Dosage Form: Tablets, Capsules, Injections, Suppositories
4) By Application: Cardiovascular Disease, Pain, Fever, O Inflammation, Other Applications
5) By End User: Hospitals, Clinics, Other End Users

Aspirin Market Major Players and Strategies
Major players in the aspirin market are Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health, Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co., Ltd., LNK International, Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co., Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited and St. Joseph’s Aspirin.

Philip Morris International (PMI), Inc., a tobacco business located in the United States, acquired OtiTopic for an unknown sum in August 2021. This acquisition contributes to PMI’s strategic goal of expanding its pipeline of inhaled medicines and respiratory medication delivery Beyond Nicotine by using its experience, scientific know-how, and inhalation capabilities. OtiTopic is a respiratory medication development firm based in the United States that is working on an inhalable acetylsalicylic acid (ASA) therapy for acute myocardial infarction. OtiTopic is the creator of an aspirin dry powder inhaled formulation.

The Aspirin Global Market Report 2023 covers regional data on aspirin market size, aspirin market trends and drivers, opportunities, strategies, and aspirin market competitor analysis. The countries covered in the aspirin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Aspirin is a nonsteroidal anti-inflammatory medication that is commonly used to treat fever and minor pains. Acetylsalicylic acid (ASA) is the chemical name for aspirin. It is used to treat illnesses such as arthritis and to lower the risk of complications such as heart attack and stroke.

View More Reports Related To The Aspirin Market –
Marketing Research And Analysis Services Global Market Report 2023
Marketing Automation Global Market Report 2023
Market Research Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: